0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Januvia:

Januvia 25mg
Januvia 50mg
Januvia 100mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Januvia:

  • Albania
  • Australia
  • Azerbaijan
  • Bahamas
  • Bosnia and Herzegovina
  • Cayman Islands
  • Cook Islands
  • Costa Rica
  • Croatia
  • Ecuador
  • Estonia
  • Georgia
  • Germany
  • Honduras
  • India
  • Iran
  • Iraq
  • Jamaica
  • Korea, South
  • Latvia
  • Mauritius
  • Morocco
  • Netherlands Antilles
  • Nicaragua
  • Paraguay
  • Poland
  • Romania
  • Seychelles
  • Singapore
  • Spain
  • Sweden
  • Tonga
  • Ukraine
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Venezuela
  • Vietnam
  • Yemen
View All Countries

Latest news releases on Januvia:

Merck expects bumpy ride due to generics - CBS News

Frazier noted the company's Januvia family of diabetes pills has become No. 1 worldwide among branded diabetes medicines. It's been buoyed by the approvals last year of Juvisync, the first combo pill for people with diabetes and cholesterol ...

Study: Docs barring pharma reps has unexpected side effects - FiercePharma

It cut back on adoption of a brand-new, first-in-class diabetes drug--Merck's ($MRK) Januvia--which could be good for healthcare costs, but potentially kept patients from a therapy that might work better for them, the study authors concluded.

Amylin Said to Draw First-Round Bids From Sanofi, Merck - Bloomberg

Merck, in Whitehouse Station, New Jersey, sells the diabetes drugs Januvia and Janumet, which drew $919 million and $392 million in first-quarter revenue, respectively. Purchasing Amylin would make sense for the drugmaker because “they’ve ...

Novo’s Insulin Pill Quest is Holy Grail for Diabetics - Bloomberg

New hires include Nazaneen Pourkavoos, who helped develop an extended-release version of Janumet, a pill that combines the Januvia diabetes treatment with an older drug known as metformin, for Merck & Co. (MRK) Pourkavoos, whose role is to find ...

Merck CEO: Generics, economy to make 2012-13 tough - Yahoo Finance

Frazier noted the company's Januvia family of diabetes pills has become No. 1 worldwide among branded diabetes medicines. It's been buoyed by the approvals last year of Juvisync, the first combo pill for people with diabetes and cholesterol ...

Merck: Manufacturing Portfolio Health With Dividend Income - Seekingalpha.com

Revenue climbed 1.3 percent to $11.7 billion, boosted by sales of the Januvia and Janumet diabetes drugs. Net income for Merck & Co Inc. rose to $1.74 billion (56 cents per share) vs. $1.04 billion (34 cents per share) in the same quarter a year earlier.

Diabetes Drug Shown to Work in Blacks - MedPage Today

Unlike the other approved DPP-4 inhibitors sitagliptin (Januvia) and saxagliptin (Onglyza), linagliptin is not excreted through the kidneys. Linagliptin has been studied as monotherapy or as an add-on to metformin, glimepiride, or pioglitazone ...

Canada Drugs Online Provides Cost-Cutting Strategies and Lower Prices on Branded Diabetes Drugs - YAHOO!

They may buy Januvia or generic Glucophage for significantly lower prices than they could find in the United States. Canada Drugs Online is proudly verified by PharmacyChecker.com and is a Certified Canadian International Pharmacy (CIPA).

Facing better odds, Novo Nordisk working on blockbuster insulin pill - NJ.com

New hires include Nazaneen Pourkavoos, who helped develop an extended-release version of Janumet, a pill that combines the Januvia diabetes treatment with an older drug known as metformin, for Merck & Co. crossing the gut barrier Pourkavoos ...

Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 - new market research report - Transworld News

In 2011, Lantus was the leading drug, with approximate sales worth $3.6 billion and a market share of 18%. Januvia/Janumet, the DPP4 inhibitor was the second leading drug, with approximate sales of $3.4 billion and a market share of 17.1%. Actos was the ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK